Occupational Thorium Exposure or Self-Poisoning?
Thoriated electrodes are used in TIG (Tungsten Inert Gas) welding [1]. Thorium intake may happen during grinding and welding operations using thoriated electrodes [2]. The use of thoriated tungsten electrodes may be at the origin of a potential hazard [3]. The annual commited effective dose from inhalation of 232Th, 230Th, 228Th and 228Ra is usually below 1mSv for a full-time TIG welder [4]. Electrode consumption during welding was primarily the result of tip sharpening. Indeed, less than 3% of weight loss was attributable to the welding process [5].
Thorium-232 exposure during tungsten inert gas arc welding and electrode sharpening.
To assess the exposure of welders to thorium-232 (232Th) during tungsten inert gas arc (TIG) welding, airborne concentrations of 232Th in the breathing zone of the welder and background levels were measured. The radioactive concentrations were 1.11 x 10(-2) Bq/m3 during TIG welding of aluminum (TIG/Al), 1.78 x 10(-4) Bq/m3 during TIG welding of stainless steel (TIG/SS), and 1.93 x 10(-1) Bq/m3 during electrode sharpening, with 5.82 x 10(-5) Bq/m3 background concentration. Although the annual intake of 232Th estimated using these values did not exceed the annual limit intake (ALI, 1.6 x 10(2) Bq), we recommend reducing 232Th exposure by substituting thoriated electrodes with a thorium-free electrodes, setting up local ventilation systems, and by using respiratory protective equipment. It is also necessary to inform workers that thoriated tungsten electrodes contain radioactive material.
Determination of thorium in the organs of deceased thorotrast patients
Abstract“Thorotrast” was widely used in the past as an X-ray contrast medium, containing a colloidal solution of thorium dioxide (232ThO2). After injection, thorium accumulates and is mainly retained in the liver. Thus once Thorotrast is administered, patients might be chronically exposed to α-radiations. Recently, significant development of cirrhosis and cancer of the liver has often been noted among Thorotrast patients. Additionally the incidence of lung and breast disease has significantly increased. Thus, the assessment of internal radiation dose from deposits of Thorotrast is very important. In this report, the thorium content in various organs was determined by means of neutron activation analysis. All the samples were taken from organs of Thorotrast patients subsequent to death. The ashed samples were irradiated in a reactor. After cooling, the content of thorium was determined by measurement of gamma rays resulting from the decay of protactinium-233. For comparison, measurements by other analytical methods such as inductively coupled plasma mass spectrometry, colorimetric analysis using ArsenazoIII and radiation measurement of γ-rays from actinium-228, were carried out.